Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06701812 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Digoxin Medulloblastoma Study

StatusRecruiting
PhasePhase 2
Started2026-01-15
View on ClinicalTrials.gov ↗

Amendment history

2026-08-25
Study Status, Contacts/Locations v10
Study sites15→17
2026-07-02
Study Status, Contacts/Locations v9
Study sitesdetails revised at 1 of 15 sites
2026-02-25
Study Status v8
Primary completion date2026-02→2027-02
Start dateestimated 2025-12→confirmed 2026-01-15
2025-12-17
Study Status, Contacts/Locations v7
Study sites14→15
2025-10-30
Study Status, Contacts/Locations v6
Study sitesdetails revised at 1 of 14 sites
Show 5 earlier versions
2025-09-09
Study Status v5
Start date2025-07→2025-12
2025-06-02
Study Status, Contacts/Locations v4
Start date2025-05→2025-07
Study sitesdetails revised at 2 of 14 sites
2025-04-21
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start date2025-03→2025-05
Study sitesdetails revised at 14 of 14 sites
2025-02-10
Study Status v2
Start date2025-01→2025-03
2024-12-18
Study Status, Contacts/Locations v1
Start date2024-11→2025-01
Study sitescontacts updated at 14 of 14 sites
2024-11-20
Original filing
The purpose of this study is to evaluate the efficacy of digoxin in treating relapsed non-SHH, non-WNT medulloblastoma in pediatric and young adult patients.
Trial Details
NCT Number NCT06701812
Lead Sponsor H. Lee Moffitt Cancer Center and Research Institute
Collaborators: National Pediatric Cancer Foundation
Conditions Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Enrollment 23 participants
Start Date 2026-01-15
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-08-26